Scinai Immunotherapeutics
SCNI
6 hedge funds and large institutions have $3.12M invested in Scinai Immunotherapeutics in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
30% less capital invested
Capital invested by funds: $4.43M → $3.12M (-$1.31M)
33% less funds holding
Funds holding: 9 → 6 (-3)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$62K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$17.7K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$17.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mariner
Overland Park,
Kansas
|
-$525K |
| 2 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
-$232K |
| 3 |
II
Ibex Investors
Denver,
Colorado
|
-$17.7K |
| 4 |
Morgan Stanley
New York
|
-$8.86K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |
SCNI Hedge Fund Activity: Q1 2020 in Review
6 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Scinai Immunotherapeutics (SCNI) for Q1 2020, worth a combined $3.12M — down 30% from $4.43M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SCNI and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was Renaissance Technologies, adding an estimated $62K. The largest seller was Mariner, exiting entirely with an estimated $525K sold.
- 6 institutional investors held Scinai Immunotherapeutics (SCNI) as of Q1 2020, down from 9 in Q4 2019.
- Funds reported $3.12M of Scinai Immunotherapeutics stock for Q1 2020, down 30% quarter-over-quarter.
- 1 fund opened new Scinai Immunotherapeutics positions in Q1 2020 and 3 closed out, a net change of -2 holders.
- The largest Scinai Immunotherapeutics buyer in Q1 2020 was Renaissance Technologies, an estimated $62K added.
- The largest Scinai Immunotherapeutics seller in Q1 2020 was Mariner, an estimated $525K sold.
Based on aggregated 13F filings for Q1 2020.